| Overview | |
| Research and Development technology company specializing in the application of life science technologies to address market needs across a broad spectrum of industries. | |
| Keywords : life, science, avian, flu, influenza, biotech, hiv, aids, biotechnology, regenerative, nanotechnology, liposome, liposomal, hsv2, molecular, vaccine, therapeutics, biomedical, diagnostics, immunology, VesiVax, angiogenisis, adjuvant, disintegrins, anthrax | |
| H1 tags : Molecular Express announces award of SBIR Advanced Technology Phase I funding from the National Institute of Allergy and Infectious Diseases to continue development of an influenza vaccine; Molecular Express announces award of SBIR Phase II funding from the National Heart Lung and Blood Institute to develop a synthetic lung surfactant; Molecular Express announces award of SBIR Phase I funding from the National Institute of Allergy and Infectious Diseases Advanced Technology program to develop an adjuvant system |
| Last Update : | 27/December/2011 |
| Google PR : | 5 |
| Internal links : | 25 |
| Archive : | Check how did the site look in the past? |